Reviewed,
UniProtKB/Swiss-Prot O60934 (NBN_HUMAN)
Last modified
November 25, 2008.
Version 67.
History...
Clusters with 100%,
90%,
50% identity |
Documents (5) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Nibrin Alternative name(s): Nijmegen breakage syndrome protein 1 Cell cycle regulatory protein p95 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 754 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Component of the MRE11/RAD50/NBN (MRN complex) which plays a critical role in the cellular response to DNA damage and the maintenance of chromosome integrity. The complex is involved in double-strand break (DSB) repair, DNA recombination, maintenance of telomere integrity, cell cycle checkpoint control and meiosis. The complex possesses single-strand endonuclease activity and double-strand-specific 3'-5' exonuclease activity, which are provided by MRE11A. RAD50 may be required to bind DNA ends and hold them in close proximity. NBN modulate the DNA damage signal sensing by recruiting PI3/PI4-kinase family members ATM, ATR, and probably DNA-PKcs to the DNA damage sites and activating their functions. It can also recruit MRE11 and RAD50 to the proximity of DSBs by an interaction with the histone H2AX. NBN also functions in telomere length maintenance by generating the 3' overhang which serves as a primer for telomerase dependent telomere elongation. NBN is a major player in the control of intra-S-phase checkpoint and there is some evidence that NBN is involved in G1 and G2 checkpoints. The roles of NBS1/MRN encompass DNA damage sensor, signal transducer, and effector, which enable cells to maintain DNA integrity and genomic stability. |
| Subunit structure | Component of the MRN complex composed of two heterodimers RAD50/MRE11A associated with a single NBN. Component of the BASC complex, at least composed of BRCA1, MSH2, MSH6, MLH1, ATM, BLM, RAD50 and MRE11A By similarity. Interacts with histone H2AFX this requires phosphorylation of H2AFX on 'Ser-139'. Interacts with HJURP, KPNA2 and TERF2. |
| Subcellular location | NucleusBy similarity. TelomereBy similarity. Note= Localizes to discrete nuclear foci after treatment with genotoxic agents By similarity. |
| Tissue specificity | Ubiquitous. Expressed at high levels in testis. |
| Domain | The FHA and BRCT domains are likely to have a crucial role for both binding to histone H2AFX and for relocalization of MRE11/RAD50 complex to the vicinity of DNA damage. The C-terminal domain contains a MRE11-binding site, and this interaction is required for the nuclear localization of the MRN complex. The EEXXXDDL motif at the C-terminus is required for the interaction with ATM and its recruitment to sites of DNA damage and promote the phosphorylation of ATM substrates, leading to the events of DNA damage response. |
| Post-translational modification | Phosphorylated by ATM in response of ionizing radiation, and such phosphorylation is responsible intra-S phase checkpoint control and telomere maintenance. |
| Involvement in disease | Defects in NBN are the cause of Nijmegen breakage syndrome (NBS) [MIM:251260]. NBS is an autosomal recessive syndrome characterized by chromosomal instability, radiation sensitivity, microcephaly, growth retardation, immunodeficiency and predisposition to cancer, particularly to lymphoid malignancies. Defects in NBN are a cause of genetic susceptibility to breast cancer (BC) [MIM:114480]. BC is an extremely common malignancy, affecting one in eight women during their lifetime. A positive family history has been identified as major contributor to risk of development of the disease, and this link is striking for early-onset breast cancer. Defects in NBN may be associated with aplastic anemia [MIM:609135]. Aplastic anemia is a disease of bone-marrow failure characterized by peripheral pancytopenia and marrow hypoplasia. Most of the cases of aplastic anemia are idiopathic, some are familial and some are due to a viral infection or to exposure to chemicals and radiation. Defects in NBN might play a role in the pathogenesis of childhood acute lymphoblastic leukemia (ALL). |
| Miscellaneous | In case of infection by adenovirus E4, the MRN complex is inactivated and degraded by viral oncoproteins, thereby preventing concatenation of viral genomes in infected cells. |
| Sequence similarities | Contains 1 BRCT domain. Contains 1 FHA domain. |
| Sequence caution | The sequence AAI08651.1 differs from that shown. Reason: Miscellaneous discrepancy. Contaminating sequence. Potential poly-A sequence starting in position 550. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| CCNE1 | P24864 | 1 | EBI-494844,EBI-519526 | |
| H2AFX | P16104 | 6 | EBI-494844,EBI-494830 | |
| MDC1 | Q14676 | 2 | EBI-494844,EBI-495644 | |
| MRE11A | P49959 | 1 | EBI-494844,EBI-396513 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 754 | 754 | Nibrin | PRO_0000231043 | |||||
Regions | |||||||||
| Domain | 24 – 83 | 60 | FHA | ||||||
| Domain | 105 – 181 | 77 | BRCT | ||||||
| Motif | 461 – 467 | 7 | Nuclear localization signal | ||||||
| Motif | 736 – 743 | 8 | EEXXXDDL motif | ||||||
| Compositional bias | 448 – 451 | 4 | Poly-Gln | ||||||
Amino acid modifications | |||||||||
| Modified residue | 278 | 1 | Phosphoserine; by ATM | ||||||
| Modified residue | 343 | 1 | Phosphoserine; by ATM | ||||||
| Modified residue | 397 | 1 | Phosphoserine | ||||||
| Modified residue | 432 | 1 | Phosphoserine | ||||||
| Modified residue | 615 | 1 | Phosphoserine | ||||||
Natural variations | |||||||||
| Natural variant | 93 | 1 | S → L in some childhood acute lymphoblastic leukemia patients; uncertain pathological significance; rare variant. | VAR_025792 | |||||
| Natural variant | 95 | 1 | D → N in some childhood acute lymphoblastic leukemia patients; uncertain pathological significance; rare variant. | VAR_025793 | |||||
| Natural variant | 105 | 1 | K → N: dbSNP rs13312858. | VAR_025794 | |||||
| Natural variant | 150 | 1 | L → F in BC. | VAR_025795 | |||||
| Natural variant | 171 | 1 | I → V in some childhood acute lymphoblastic leukemia patients; uncertain pathological significance; rare variant; associated with aplastic anemia at homozygosity. | VAR_025796 | |||||
| Natural variant | 185 | 1 | E → Q: dbSNP rs1805794. | VAR_025797 | |||||
| Natural variant | 210 | 1 | V → F | VAR_025798 | |||||
| Natural variant | 215 | 1 | R → W | VAR_025799 | |||||
| Natural variant | 216 | 1 | Q → K: dbSNP rs769416. | VAR_025800 | |||||
| Natural variant | 266 | 1 | P → L: dbSNP rs769420. | VAR_025801 | |||||
| Natural variant | 497 | 1 | T → A: dbSNP rs3026268. | VAR_025802 | |||||
| Natural variant | 574 | 1 | L → I | VAR_025803 | |||||
Experimental info | |||||||||
| Mutagenesis | 28 | 1 | R → A: Disrupts nuclear foci formation and block phosphorylation in response to ionizing radiation | ||||||
| Mutagenesis | 45 | 1 | H → A: Disrupts nuclear foci formation and block phosphorylation in response to ionizing radiation | ||||||
| Mutagenesis | 136 – 137 | 2 | GG → EE: Disrupts nuclear foci formation and block phosphorylation in response to ionizing radiation | ||||||
| Mutagenesis | 176 | 1 | Y → A: Disrupts nuclear foci formation and block phosphorylation in response to ionizing radiation | ||||||
| Mutagenesis | 343 | 1 | S → A: Abrogates ATM-dependent phosphorylation | ||||||
| Mutagenesis | 397 | 1 | S → A: Abrogates ATM-dependent phosphorylation. No loss of interaction with KPNA2 | ||||||
| Mutagenesis | 465 – 466 | 2 | KR → AA: Blocks the association with KPNA2, and reduces nuclear foci formation in response to ionizing radiation | ||||||
| Mutagenesis | 583 | 1 | Q → K: No loss of interaction with KPNA2 | ||||||
| Mutagenesis | 615 | 1 | S → A: Abrogates ATM-dependent phosphorylation | ||||||
| Mutagenesis | 736 – 737 | 2 | EE → AA: Decreases ATM binding | ||||||
| Mutagenesis | 741 – 742 | 2 | DD → AA: Decreases ATM binding | ||||||
| Mutagenesis | 745 – 746 | 2 | RY → AA: Decreases ATM binding | ||||||
| Sequence conflict | 247 | 1 | G → R in BAD96976. Ref.5 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome." Varon R., Vissinga C., Platzer M., Cerosaletti K.M., Chrzanowska K.H., Saar K., Beckmann G., Seemanova E., Cooper P.R., Nowak N.J., Stumm M., Weemaes C.M.R., Gatti R.A., Wilson R.K., Digweed M., Rosenthal A., Sperling K., Concannon P., Reis A. Cell 93:467-476(1998) [PubMed: 9590180] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], INVOLVEMENT IN NIJMEGEN BREAKAGE SYNDROME, VARIANT GLN-185. |
| [2] | "The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response." Carney J.P., Maser R.S., Olivares H., Davis E.M., Le Beau M., Yates J.R. III, Hays L., Morgan W.F., Petrini J.H.J. Cell 93:477-486(1998) [PubMed: 9590181] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 189-209; 238-250; 289-299; 300-320; 335-351; 395-405; 409-423; 426-441; 457-465; 503-529; 552-568; 595-613; 625-635; 653-660; 671-683 AND 736-745, VARIANT GLN-185, INTERACTION WITH MRE11 AND RAD50. |
| [3] | "Positional cloning of the gene for Nijmegen breakage syndrome." Matsuura S., Tauchi H., Nakamura A., Kondo N., Sakamoto S., Endo S., Smeets D., Solder B., Belohradsky B.H., Kaloustian V.M., Oshimura M., Isomura M., Nakamura Y., Komatsu K. Nat. Genet. 19:179-181(1998) [PubMed: 9620777] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [4] | "Sequence analysis of an 800-kb genomic DNA region on chromosome 8q21 that contains the Nijmegen breakage syndrome gene, NBS1." Tauchi H., Matsuura S., Isomura M., Kinjo T., Nakamura A., Sakamoto S., Kondo N., Endo S., Komatsu K., Nakamura Y. Genomics 55:242-247(1999) [PubMed: 9933573] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. Tissue: Fibroblast. |
| [5] | Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S. Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Synovial cell. |
| [6] | "NIEHS-SNPs, environmental genome project, NIEHS ES15478, Department of Genome Sciences, Seattle, WA (URL: http://egp.gs.washington.edu)." Livingston R.J., Rieder M.J., Chung M.-W., Ritchie T.K., Olson A.N., Nguyen C.P., Nguyen D.A., Poel C.L., Chambers S.W., Schackwitz W.S., Sherwood J.K., Sherwood A.M., Leithauser B.J., Nickerson D.A. Submitted (MAR-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS ASN-105; GLN-185; LYS-216; LEU-266 AND ALA-497. |
| [7] | The German cDNA consortium Submitted (SEP-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 58-754. Tissue: Colon endothelium. |
| [8] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 68-550. Tissue: Skin. |
| [9] | "Nuclease activities in a complex of human recombination and DNA repair factors Rad50, Mre11, and p95." Trujillo K.M., Yuan S.-S.F., Lee E.Y.-H.P., Sung P. J. Biol. Chem. 273:21447-21450(1998) [PubMed: 9705271] [Abstract] Cited for: FUNCTION IN DSB REPAIR, IDENTIFICATION IN THE MRN COMPLEX WITH MRE11A AND RAD50. |
| [10] | "Distinct functional domains of nibrin mediate Mre11 binding, focus formation, and nuclear localization." Desai-Mehta A., Cerosaletti K.M., Concannon P. Mol. Cell. Biol. 21:2184-2191(2001) [PubMed: 11238951] [Abstract] Cited for: INTERACTION WITH MRE11. |
| [11] | "ATM-dependent phosphorylation of nibrin in response to radiation exposure." Gatei M., Young D., Cerosaletti K.M., Desai-Mehta A., Spring K., Kozlov S., Lavin M.F., Gatti R.A., Concannon P., Khanna K.K. Nat. Genet. 25:115-119(2000) [PubMed: 10802669] [Abstract] Cited for: PHOSPHORYLATION AT SER-343, MUTAGENESIS OF ARG-28; HIS-45; 136-GLY-GLY-137 AND TYR-176. |
| [12] | "Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products." Zhao S., Weng Y.-C., Yuan S.-S.F., Lin Y.-T., Hsu H.-C., Lin S.-C., Gerbino E., Song M.-H., Zdzienicka M.Z., Gatti R.A., Shay J.W., Ziv Y., Shiloh Y., Lee E.Y.-H.P. Nature 405:473-477(2000) [PubMed: 10839544] [Abstract] Cited for: PHOSPHORYLATION AT SER-278. |
| [13] | "ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response." Wu X., Ranganathan V., Weisman D.S., Heine W.F., Ciccone D.N., O'Neill T.B., Crick K.E., Pierce K.A., Lane W.S., Rathbun G., Livingston D.M., Weaver D.T. Nature 405:477-482(2000) [PubMed: 10839545] [Abstract] Cited for: PHOSPHORYLATION AT SER-343; SER-397 AND SER-615, MUTAGENESIS OF SER-343; SER-397 AND SER-615. |
| [14] | "Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres." Zhu X.-D., Kuester B., Mann M., Petrini J.H.J., de Lange T. Nat. Genet. 25:347-352(2000) [PubMed: 10888888] [Abstract] Cited for: FUNCTION IN TELOMERES, IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION IN A COMPLEX WITH TERF2. |
| [15] | "NBS1 localizes to gamma-H2AX foci through interaction with the FHA/BRCT domain." Kobayashi J., Tauchi H., Sakamoto S., Nakamura A., Morishima K., Matsuura S., Kobayashi T., Tamai K., Tanimoto K., Komatsu K. Curr. Biol. 12:1846-1851(2002) [PubMed: 12419185] [Abstract] Cited for: INTERACTION WITH H2AFX. |
| [16] | "Large-scale characterization of HeLa cell nuclear phosphoproteins." Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., Cohn M.A., Cantley L.C., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004) [PubMed: 15302935] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-343, MASS SPECTROMETRY. Tissue: Epithelium. |
| [17] | "Importin KPNA2 is required for proper nuclear localization and multiple functions of NBS1." Tseng S.-F., Chang C.-Y., Wu K.-J., Teng S.-C. J. Biol. Chem. 280:39594-39600(2005) [PubMed: 16188882] [Abstract] Cited for: INTERACTION WITH KPNA2, MUTAGENESIS OF SER-397; 465-LYS-ARG-466 AND GLN-583. |
| [18] | "Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage." Falck J., Coates J., Jackson S.P. Nature 434:605-611(2005) [PubMed: 15758953] [Abstract] Cited for: DOMAIN, MUTAGENESIS OF 736-GLU-GLU-737; 741-ASP-ASP-742 AND 745-ARG-TYR-746. |
| [19] | "Nbs1 is required for ATR-dependent phosphorylation events." Stiff T., Reis C., Alderton G.K., Woodbine L., O'Driscoll M., Jeggo P.A. EMBO J. 24:199-208(2005) [PubMed: 15616588] [Abstract] Cited for: FUNCTION. |
| [20] | "The role of NBS1 in DNA double strand break repair, telomere stability, and cell cycle checkpoint control." Zhang Y., Zhou J., Lim C.U. Cell Res. 16:45-54(2006) [PubMed: 16467875] [Abstract] Cited for: REVIEW. |
| [21] | "Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex." Stracker T.H., Carson C.T., Weitzman M.D. Nature 418:348-352(2002) [PubMed: 12124628] [Abstract] Cited for: INACTIVATION BY ADENOVIRUS ONCOPROTEINS. |
| [22] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed: 16964243] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-432, MASS SPECTROMETRY. Tissue: Epithelium. |
| [23] | "Activation of Holliday junction recognizing protein involved in the chromosomal stability and immortality of cancer cells." Kato T., Sato N., Hayama S., Yamabuki T., Ito T., Miyamoto M., Kondo S., Nakamura Y., Daigo Y. Cancer Res. 67:8544-8553(2007) [PubMed: 17823411] [Abstract] Cited for: INTERACTION WITH HJURP. |
| [24] | "ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage." Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J. Science 316:1160-1166(2007) [PubMed: 17525332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-343 AND SER-397, MASS SPECTROMETRY. |
| [25] | "Mutations in the Nijmegen breakage syndrome gene (NBS1) in childhood acute lymphoblastic leukemia (ALL)." Varon R., Reis A., Henze G., von Einsiedel H.G., Sperling K., Seeger K. Cancer Res. 61:3570-3572(2001) [PubMed: 11325820] [Abstract] Cited for: VARIANTS LEU-93; ASN-95; VAL-171; PHE-210 AND TRP-215, POSSIBLE INVOLVEMENT IN CHILDHOOD ACUTE LYMPHOBLASTIC ANEMIA. |
| [26] | "Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibility." Heikkinen K., Karppinen S.-M., Soini Y., Maekinen M., Winqvist R. J. Med. Genet. 40:E131-E131(2003) [PubMed: 14684699] [Abstract] Cited for: VARIANT BC PHE-150, VARIANTS GLN-185 AND ILE-574. |
| [27] | "Polymorphisms in DNA repair and metabolic genes in bladder cancer." Sanyal S., Festa F., Sakano S., Zhang Z., Steineck G., Norming U., Wijkstroem H., Larsson P., Kumar R., Hemminki K. Carcinogenesis 25:729-734(2004) [PubMed: 14688016] [Abstract] Cited for: VARIANT GLN-185. |
| [28] | "First case of aplastic anemia in a Japanese child with a homozygous missense mutation in the NBS1 gene (I171V) associated with genomic instability." Shimada H., Shimizu K., Mimaki S., Sakiyama T., Mori T., Shimasaki N., Yokota J., Nakachi K., Ohta T., Ohki M. Hum. Genet. 115:372-376(2004) [PubMed: 15338273] [Abstract] Cited for: VARIANT VAL-171. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| AF051334 mRNA. Translation: AAC39732.1. AF058696 mRNA. Translation: AAC39752.1. AB013139 Genomic DNA. Translation: BAA28616.1. AF069291 Genomic DNA. Translation: AAC62232.1. AK223256 mRNA. Translation: BAD96976.1. Different initiation. AY566246 Genomic DNA. Translation: AAS59158.1. BC108650 mRNA. Translation: AAI08651.1. Sequence problems. BX640816 mRNA. Translation: CAH56160.1. Different initiation. | |
| PIR | T00393. |
| RefSeq | NP_002476.2. |
| UniGene | Hs.492208 |
3D structure databases | |

Clusters with